Salpingectomy in Ovarian Cancer Prevention
Cette étude fait le point sur l'utilisation de la salpingectomie pour prévenir un cancer de l'ovaire aux États-Unis
Nearly 20 000 women are diagnosed with ovarian cancer in the US each year, and approximately 80% have the most lethal subtype: high-grade serous carcinoma. The vast majority of patients have no risk factors, have widely metastatic disease at symptom onset, and die within 5 years of diagnosis. Hope for efficacious screening and prevention strategies has been long-standing. The recent results of the United Kingdom Collaborative Trial of Ovarian Cancer Screening, the largest ovarian cancer screening trial in history, were unsettling. Although screening resulted in an increase in earlier-stage diagnosis, this did not translate into lives saved.